Massimo Bernardi

9.8k total citations
127 papers, 3.2k citations indexed

About

Massimo Bernardi is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Massimo Bernardi has authored 127 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 34 papers in Oncology and 24 papers in Immunology. Recurrent topics in Massimo Bernardi's work include Hematopoietic Stem Cell Transplantation (37 papers), Acute Myeloid Leukemia Research (33 papers) and Immune Cell Function and Interaction (17 papers). Massimo Bernardi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (37 papers), Acute Myeloid Leukemia Research (33 papers) and Immune Cell Function and Interaction (17 papers). Massimo Bernardi collaborates with scholars based in Italy, France and United States. Massimo Bernardi's co-authors include Fabio Ciceri, Jacopo Peccatori, Claudio Bordignon, Chiara Bonini, Adriano Mari, Maria Teresa Lupo Stanghellini, Attilio Bondanza, Maurilio Ponzoni, R. Ferrara and Claudia Alessandri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Massimo Bernardi

119 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Bernardi Italy 30 1.1k 994 633 631 499 127 3.2k
S.M. MacDonald United Kingdom 7 781 0.7× 372 0.4× 951 1.5× 781 1.2× 392 0.8× 9 3.2k
A K Ghosh United Kingdom 19 1.2k 1.1× 371 0.4× 1.2k 1.8× 983 1.6× 377 0.8× 31 4.1k
Jean Roudier France 39 668 0.6× 392 0.4× 1.5k 2.4× 781 1.2× 167 0.3× 136 4.1k
Fang Liao United States 20 1.7k 1.5× 641 0.6× 2.5k 3.9× 883 1.4× 626 1.3× 45 4.2k
J Brochier France 34 1.2k 1.1× 1.1k 1.1× 1.4k 2.2× 1.1k 1.7× 250 0.5× 135 3.8k
Kenneth F. Bradstock Australia 37 1.3k 1.1× 2.3k 2.3× 1.3k 2.1× 1.4k 2.2× 184 0.4× 156 4.7k
Z. Abdulaziz United Kingdom 9 871 0.8× 393 0.4× 1.1k 1.7× 938 1.5× 422 0.8× 9 3.7k
A. Lindemann Germany 32 1.1k 1.0× 892 0.9× 1.8k 2.8× 749 1.2× 126 0.3× 87 3.3k
Reinhard Marks Germany 20 787 0.7× 408 0.4× 969 1.5× 412 0.7× 165 0.3× 49 2.4k
Makoto Hirokawa Japan 28 405 0.4× 576 0.6× 983 1.6× 363 0.6× 127 0.3× 121 2.6k

Countries citing papers authored by Massimo Bernardi

Since Specialization
Citations

This map shows the geographic impact of Massimo Bernardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Bernardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Bernardi more than expected).

Fields of papers citing papers by Massimo Bernardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Bernardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Bernardi. The network helps show where Massimo Bernardi may publish in the future.

Co-authorship network of co-authors of Massimo Bernardi

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Bernardi. A scholar is included among the top collaborators of Massimo Bernardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Bernardi. Massimo Bernardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomelleri, Alessandro, Carmelo Gurnari, Marco Matucci‐Cerinic, et al.. (2025). Safety and effectiveness of the combination of 5‐azacitidine and ruxolitinib in VEXAS syndrome: A single‐centre experience. British Journal of Haematology. 208(3). 1133–1137.
2.
Campochiaro, Corrado, Alessandro Tomelleri, Maurilio Ponzoni, et al.. (2024). Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort. Frontiers in Immunology. 15. 1354130–1354130. 6 indexed citations
3.
Bruno, Alessandro, Raffaella Greco, Daniela Clerici, et al.. (2024). Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Frontiers in Oncology. 14. 1391743–1391743. 2 indexed citations
5.
Vergnenègre, A., I. Monnet, Charles Ricordel, et al.. (2023). Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo). Lung Cancer. 178. 191–197. 5 indexed citations
7.
Lorentino, Francesca, Alessandro Bruno, Sarah Marktel, et al.. (2022). Minnesota acute graft-<i>versus</i>-host disease risk score predicts survival at onset of graft-<i>versus</i>-host disease after post-transplant cyclophosphamide prophylaxis. Haematologica. 107(11). 2748–2751. 1 indexed citations
8.
Garavaglia, C, Andrea Grilli, Claudia de Lalla, et al.. (2021). Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia. Nature Communications. 12(1). 4844–4844. 7 indexed citations
9.
Ruggeri, Annalisa, Maria Teresa Lupo Stanghellini, Sara Mastaglio, et al.. (2021). Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial. Frontiers in Oncology. 11. 731478–731478. 7 indexed citations
10.
Guisier, Florian, Catherine Dubos‐Arvis, F. Viñas, et al.. (2020). Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018. Journal of Thoracic Oncology. 15(4). 628–636. 215 indexed citations
11.
Borlenghi, Erika, Chiara Pagani, Patrizia Zappasodi, et al.. (2020). Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL). Journal of Geriatric Oncology. 12(4). 550–556. 13 indexed citations
12.
Forcina, Alessandra, Francesca Lorentino, Chiara Oltolini, et al.. (2018). Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(7). 1476–1482. 38 indexed citations
13.
Sato, Junko, et al.. (2015). Association between virulence factors and antimicrobial resistance from enterotoxigenic escherichia coli isolated from pigs with diarrhea in Brazil.. ACTA SCIENTIAE VETERINARIAE. 43. 2 indexed citations
14.
Casucci, Monica, Serena Perna, Laura Falcone, et al.. (2013). Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene. Molecular Therapy. 21(2). 466–475. 17 indexed citations
15.
D’Avino, Rossana, Massimo Bernardi, Michael Wallner, et al.. (2011). Kiwifruit Act d 11 is the first member of the ripening-related protein family identified as an allergen. Allergy. 66(7). 870–877. 60 indexed citations
16.
Fisicaro, Paola, Simona Urbani, Caterina Valdatta, et al.. (2009). 120 FUNCTIONAL T CELL RESTORATION INDUCED BY PD-1/PD-L1 BLOCKADE IN CHRONIC HEPATITIS B AND C IS IMPROVED BY SIMULTANEOUS MODULATION OF THE CO-STIMULATORY CD137/CD137L PATHWAY. Journal of Hepatology. 50. S49–S49. 1 indexed citations
17.
Bregni, Marco, Massimo Bernardi, Paolo Servida, et al.. (2009). Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting. Bone Marrow Transplantation. 44(4). 237–242. 9 indexed citations
18.
Micalizzi, Ezio, et al.. (2003). Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia. 17(4). 491–494. 62 indexed citations
20.
Camba, Lionello, Luca Aldrighetti, Massimo Bernardi, et al.. (2001). Locoregional intrasplenic chemotherapy for hypersplenism in myelofibrosis. British Journal of Haematology. 114(3). 638–640. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026